Russia completes early trials of second potential Covid-19 vaccine![]() September 8, 2020 - 15:25 AMT PanARMENIAN.Net - Siberia’s Vector virology institute on Tuesday, September 8 completed early-stage human trials, known as Phase II, of a second potential Russian vaccine against COVID-19, the state consumer safety watchdog was cited by the Interfax news agency as saying. Russia registered its first vaccine candidate, developed by Moscow’s Gamaleya Institute, in August. Late-stage trials of this vaccine, due to involve 40,000 participants, were launched last week, Reuters says. Human trials of the second potential Covid-19 vaccine, a peptide-based jab, began on July 27 and involved a group of 100 volunteers, Interfax cited watchdog Rospotrebnadzor as saying. “Today ... the final group of 20 volunteers was released from hospital,” said in a statement. “All 100 volunteers were vaccinated with two doses and have completed a 23-day monitoring period in hospital. The volunteers are feeling good.” Results are due to be published on September 30, Interfax said. ![]() ![]() Azerbaijani authorities report that they have already resettled 3,000 people in the Nagorno-Karabakh town of Stepanakert. On June 10, Azerbaijani President of Azerbaijan Ilham Aliyev will leave for Turkey on a working visit. Azerbaijani President Ilham Aliyev arrived in Moscow on April 22 to hold talks with Russian counterpart Vladimir Putin. Authorities said a total of 192 Azerbaijani troops were killed and 511 were wounded during Azerbaijan’s offensive. ![]() ![]() Partner news | ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |